baber/WOPTO huggingface dataset:
Patent AT-E271514-T1 (AT)
Inventor: HENNING GUNTER
IPC: B66B23/08
Filed: 1999-11-22
Granted: 2004-08-15
Abstract: A fixture suction piece at least partly encloses, especially in a U shape, an axle and is tensioned by tensioning elements. The eyelet (20) has inset pressure elements (26) in the form of pins on which the tensioning elements (30) work. The axle runs on a bearing bolt belonging to the moving staircase or sidewalk chain and is especially in the form of a hollow axle (22).
Patent AT-E257083-T1 (AT)
Inventor: PUESCHEL UWE
IPC: B41F21/00
Filed: 1999-11-30
Granted: 2004-01-15
Abstract: Nozzles (20) are provided in the conducting surface (11) of the paper web. The nozzles can introduced an air blast or an air suction to the paper web. The size of the passage cross section of at least individual nozzles (20) is adjustable. The nozzles (20) are formed by openings (13,19, fig.4) in one of the guide vanes (11) of the wall (12). A valve element (17) is arranged on the side of the wall (12), facing away from the guide surface (11), which is movable in one or more extension directions of the wall relative to this. So that in one setting of the valve element, openings (13,19) in the wall (12) and in the valve (17), at least partly overlap each other.
Patent AT-E254022-T1 (AT)
Inventor: SETA KUNIHITO
IPC: B29C45/53
Filed: 1999-12-20
Granted: 2003-11-15
Abstract: A thermoplastic resin injection molding machine comprises a plasticating unit (B') for plasticating a thermoplastic resin, an injecting unit (A) connected to the plasticating unit (B') through a connecting passage (12) to inject the plasticated resin into a mold, and a buffering unit having a buffering chamber (21) and receiving the resin plasticated in the plasticating unit (B'). The buffering unit is contained in the plasticating unit (B') and is located in a longitudinal direction of the plasticating unit (B'). <IMAGE>
Patent AT-E227179-T1 (AT)
Inventor: RITTER KLAUS
IPC: B21F9/00
Filed: 1999-01-08
Granted: 2002-11-15
Abstract: A process and plant are disclosed for manufacturing grates made of longitudinal and transverse hot-rolled steel rods which cross one another and are welded together at their crossing points. The billet used to form the longitudinal rods is continuously withdrawn in a device (1) over a spill from a wire storage, stretched to improve its mechanical technological properties, then tempered and cut into sections. The longitudinal rods are then arranged in groups, according to the arrangement of the longitudinal rods in the grate to be produced, are moved into the working region of the grate welding machine (4) and introduced therein. The billet for forming the transverse rods is continuously withdrawn in a device (5) over a spill from a wire storage, stretched to improve its mechanical technological properties, then conveyed through a buffer storage, tempered, then each transverse rod separated from the billet is fed to the grate welding machine in time with the welding cycles.
Patent AT-E293840-T1 (AT)
Inventor: BARONE MARIA E
IPC: C23C14/54
Filed: 1999-02-18
Granted: 2005-05-15
Abstract: A method and apparatus for calibrating a semi-empirical process simulator used to determine process values in a plasma process for creating a desired surface profile on a process substrate includes providing a test model which captures all mechanisms responsible for profile evolution in terms of a set of unknown surface parameters. A set Sets of test conditions processes is are derived for which the profile evolution is governed by only a limited number of parameters. For each set of test conditions process, model test values are selected and a test substrate is substrates are actually subjected to a the test process processes defined by the test values, thereby creating a test surface profile profiles. The test values are used to generate an approximate profile prediction predictions and are adjusted to minimize the discrepancy between the test surface profile profiles and the approximate profile prediction predictions, thereby providing a final model of the profile evolution in terms of the process values.
Patent AT-E286530-T1 (AT)
Inventor: HARTSHORN RICHARD TIMOTHY
IPC: C11D3/12
Filed: 1999-07-08
Granted: 2005-01-15
Abstract: The invention provides a method for improving the dispensing of a detergent composition or component thereof, comprising a surfactant and other detergent components, by providing a detergent composition comprising an intimate mixture of the surfactant component or part thereof and a crystalline layered silicate.
Patent AT-E307586-T1 (AT)
Inventor: PINES MARK
IPC: G01N33/50
Filed: 1999-08-13
Granted: 2005-11-15
Abstract: According to the present invention compositions and methods are provided to prevent the pathogenic aspects of tissue trauma while preserving normal tissue repair mechanisms, based on the fact that these molecules abrogate the cascade of damage initiated by tissue trauma, while maintaining this the requisite healthy extracellular matrix economy. The composition for regulating the extracellular matrix economy, comprise a pharmaceutically effective amount of an effector in combination with a pharmaceutically acceptable carrier. Preferably, the effector is a quinazolinone derivative. More preferably, the quinazolinone derivative is a member of a group having formula (I), wherein R1 is a member of the group consisting of hydrogen, halogen, nitro, benzo, lower alkyl, phenyl, and lower alkoxy; R2 is a member of the group consisting of hydroxy, acetoxy, and lower alkoxy, and R3 is a member of the group consisting of hydrogen and lower alkenoxy; and pharmaceutically acceptable salts thereof; and n is either 1 or 2. Most preferably, the effector is Halofuginone and pharmaceutically acceptable salts thereof.
Patent AT-E315405-T1 (AT)
Inventor: KENSIL CHARLOTTE A
IPC: C12N15/09
Filed: 1999-08-06
Granted: 2006-02-15
Abstract: Vaccine compositions of immunostimulatory oligonucleotides and saponin adjuvants and antigens and the use thereof for stimulating immunity, enhancing cell-mediated immunity, and enhancing antibody production are disclosed. Also described are immune adjuvant compositions comprising immunostimulatory oligonucleotides and saponin adjuvants, as well as methods for increasing an immune response using the same.
Patent AT-E306978-T1 (AT)
Inventor: BOJESEN SIMON BERG
IPC: A63H33/08
Filed: 1999-12-23
Granted: 2005-11-15
Abstract: A toy building set of building elements (10, 14) having coupling means (11, 12, 13) by which building elements (10, 14) may be built together. One of the building elements (20) contains a camera, which is adapted to record images of its surroundings. A user may eg build a remote-controlled toy (30) in which the building element (20) with the camera may be arranged in positions and with an orientation at the user's option. <??>A film production system with a camera and recording and editing facilities. Movable objects and a plurality of predefined positions for the movable objects, and means for holding the movable objects in selected ones of the predefined positions when the camera records one or more images. Thereby the movable objects can be placed accurately and repeatedly in predetermined positions. The predefined positions are preferably defined by toy building elements having coupling means for interconnecting building elements. <IMAGE>
Patent AT-E262523-T1 (AT)
Inventor: GRANETO MATTHEW J
IPC: C07D239/26
Filed: 1999-11-18
Granted: 2004-04-15
Abstract: This invention relates to a novel process of preparing selected 5-substituted pyrazoles useful as p38 kinase and COX-2 inhibitors.
Patent AT-E430636-T1 (AT)
Inventor: RUNKLE JOSEPH
IPC: B22F5/00
Filed: 1999-12-22
Granted: 2009-05-15
Abstract: A method of producing a silicon aluminum sputtering target is provided. The target is formed from a powder base of between about 80% to about 95% by weight silicon and about 5% to about 20% by weight aluminum which is placed in a containment unit, heated under vacuum and then sealed. The base is then subjected to a pressure greater than about 3000 psi and heated to a temperature between about 1076° F. and about 1652° F. such that some, but not more than 30%, of the resulting target is formed from liquid phase silicon-aluminum.
Patent DE-09003262-T1 (DE)
Title: Verbessertes, verdecktes Scharnier
Inventor: AMADEO DAVIDE
IPC: E05D7/04
Filed: 2009-03-06
Abstract: Verbessertes, verdecktes Scharnier (10) insbesondere für Möbelplatten oder Türen, das aus Metall oder anderen geeigneten Materialien gefertigt ist, umfassend ein Paar Halbschalen (12–14), die dafür geeignet sind, in jeweilige Sitze einer Türe oder einer Platte (48) und eines Pfostens (46) eingesetzt zu werden, die in einer gelenkigen Weise miteinander verbunden sind und eine Aussparung (16) oder (18) aufweisen, in der ein Käfig (20) oder (22) angeordnet und gehalten ist, dadurch gekennzeichnet, dass jeder Käfig (20) oder (22) an zwei Stellen mit einer Einrichtung zum Einstellen desselben bezüglich des Freiliegens in Bezug auf die Aussparung (16) oder (18) versehen ist.
Patent DE-773999-T1 (DE)
Inventor: ENMARK EVA
IPC: C12N15/12
Filed: 1995-08-16
Abstract: This invention provides an isolated receptor having the amino acid sequence of FIG. 1 (SEQ ID NO:2) or substantially the same amino acid sequence as the amino acid sequence shown in FIG. 1 (SEQ ID NO:2) or an amino acid sequence functionally similar to that sequence, and DNA sequences encoding such a receptor.
Patent ES-2312305-T1 (ES)
Title: Procedimiento y aparato para el tratamiento de tinnitus de tono predominante.
Inventor: CHOY DANIEL S J
IPC: A61H19/00
Filed: 2006-10-23
Abstract: Dispositivo portátil de tratamiento de pacientes (100) para el tratamiento del tinnitus, comprendiendo dicho dispositivo (100): un dispositivo generador de sonidos (10, 16); y un circuito de audio para la producción, a través de dicho dispositivo generador de sonidos (10, 16), de un patrón de sonido de tratamiento, en el que dicho patrón de sonido de tratamiento comprende una frecuencia que coincide con el tinnitus de dicho paciente (11) y que presenta un desplazamiento de fase para reducir el tinnitus del paciente (11).
Patent CY-1109594-T1 (CY)
Title: Στοιχειο ασφαλειας που μεταβαλλεται απο μαυρο σε εγχρωμο
Inventor: DESPLAND CLAUDE-ALAIN
IPC: B24D15/00
Filed: 2009-11-11
Abstract: Η εφεύρεση αποκαλύπτει ένα στοιχείο ασφαλείας για τραπεζογραμμάτιο, αξιόγραφο, έγγραφο ταυτότητας ή τίτλων, εισιτήριο, ετικέτα, αναγνωριστικό προϊόντος με εμπορικό σήμα ή ταινία φορολογίας. Το στοιχείο περιλαμβάνει συνδυασμό επίχρισης που περιέχει τουλάχιστον ένα οπτικώς μεταβλητό πιγμέντο με σημαντική μεταβολή χρώματος ανάλογα με τη γωνία παρατήρησης, με τουλάχιστον ένα υλικό επιλεκτικής φασματικής απορρόφησης, το οποίο αποκόπτει τις ορατές φασματικές συνιστώσες που ανακλώνται από το οπτικώς μεταβλητό πιγμέντο κατά την ορθογώνια πρόσπτωση. Το στοιχείο ασφαλείας εμφανίζεται μαύρο όταν εξετάζεται υπό ορθή γωνία και έγχρωμο όταν εξετάζεται υπό μηδενική γωνία.
Patent CY-1117248-T1 (CY)
Title: Συνθεσεις και μεθοδοι για την αναστολη της οδου jακ
Inventor: LI HUI
IPC: C07D471/08
Filed: 2015-12-08
Abstract: Αποκαλύπτονται ενώσεις του τύπου I, συνθέσεις που τις περιέχουν, και μέθοδοι χρήσεως για τις ενώσεις και συνθέσεις για την θεραπεία καταστάσεων, στις οποίες η ρύθμιση της οδού JAK ή η αναστολή των κινασών JAK, ειδικότερα της JAK2 και JAK3, είναι θεραπευτικά χρήσιμη.
Patent CY-1117172-T1 (CY)
Title: Ενα παρεμποδιστικο μονοκλωνικο αντισωμα εναντι vla-1 και η χρηση του για τη θεραπεια φλεγμονωδων διαταραχων
Inventor: DE FOUGEROLLES ANTONIN R
IPC: A61P7/02
Filed: 2016-02-08
Abstract: Μια μέθοδος για τη θεραπεία φλεγμονωδών διαταραχών περιγράφεται, και ιδιαίτερα για τη θεραπεία μιας αγγειοπάθειας. Η μέθοδος περιλαμβάνει τη χορήγηση ενός αντισώματος παρεμπόδισης λειτουργίας που είναι ικανό να συνδέεται με έναν επίτοπο του VLA-1.
Patent CY-1119649-T1 (CY)
Title: Ταχεια παγιωση και/'η περατωση της ουσιαστικης απελευθερωσης φαρμακου σταθεροποιημενης-καταστασης
Inventor: ALESSI THOMAS R
IPC: A61M5/142
Filed: 2017-11-22
Abstract: Η παρούσα εφεύρεση απευθύνεται σε μεθόδους αγωγής για μια πάθηση ή κατάσταση, σε ένα υποκείμενο σε ανάγκη τέτοιας αγωγής, που παρέχει εναλλακτικές επιλογές σε αγωγή μέσω ένεσης που αποδίδει, σχετικά με αγωγή μέσω ένεσης, βελτιωμένες εκβάσεις αγωγής, 100% συμμόρφωση αγωγής, μειωμένες παρενέργειες, και ταχεία παγίωση και/ή περάτωση ουσιαστικής απελευθέρωσης φαρμάκου σταθεροποιημένης-κατάστασης. Η μέθοδος συμπεριλαμβάνει τυπικώς παροχή συνεχούς απελευθέρωσης ενός φαρμάκου από μια εμφυτευμένη οσμωτική ιατροτεχνολογική συσκευή απελευθέρωσης, όπου η ουσιαστική απελευθέρωση σταθεροποιημένης-κατάστασης του φαρμάκου σε θεραπευτικές συγκεντρώσεις επιτυγχάνεται τυπικώς στα πλαίσια περίπου 7 ημερών ή λιγότερο μετά από εμφύτευση της οσμωτικής ιατροτεχνολογικής συσκευής απελευθέρωσης στο υποκείμενο και η ουσιαστική απελευθέρωση σταθεροποιημένης-κατάστασης του φαρμάκου από την οσμωτική ιατροτεχνολογική συσκευή απελευθέρωσης είναι συνεχής έναντι μιας περιόδου τουλάχιστον περίπου 3 μηνών. Σε μια ενσωμάτωση, η παρούσα εφεύρεση απευθύνεται σε αγωγή του σακχαρώδους διαβήτη τύπου 2 χρησιμοποιώντας μιμητικά ινκρετίνης.
Patent CY-1123953-T1 (CY)
Title: Καθυστερημενης απελευθερωσης συνθεσεις λινακλοτιδης
Inventor: FRETZEN ANGELIKA
IPC: A61K9/16
Filed: 2020-11-26
Abstract: Η παρούσα εφεύρεση σχετίζεται με καθυστερημένης απελευθέρωσης φαρμακευτικές συνθέσεις οι οποίες περιλαμβάνουν λινακλοτίδη ή φαρμακευτικώς αποδεκτά άλατα αυτής, καθώς επίσης με διάφορες μεθόδους και διαδικασίες για την παρασκευή και χρήση των συνθέσεων.
Patent CY-1126057-T1 (CY)
Title: Νεο αλας ενος αναστολεα bcl-2, σχετικη κρυσταλλικη μορφη, μεθοδος για παρασκευη αυτοy kai φαρμακευτικες συνθεσεις που περιεχουν αυτο
Inventor: LYNCH MICHAEL
IPC: C07D401/14
Filed: 2023-05-18
Abstract: Νέο άλας και σχετικές κρυσταλλικές μορφές της Ένωσης (Α), όπου το άλας είναι το όξινο θειικό άλας, που χαρακτηρίζεται από το διάγραμμα περίθλασης σκόνης ακτίνων-Χ αυτού, μέθοδος παρασκευής του ιδίου και φαρμακευτικές συνθέσεις που περιέχουν αυτό.
Patent GR-900300067-T1 (GR)
Title: A process for the production of dehydrated compressed food products
Inventor: COSTANZO LUIGI
IPC: A23K1/00
Filed: 1991-07-31
Abstract: A process for the production of dehydrated compressed food products, said process comprising the steps, starting from base freeze-dried or dried food products, as individual products or as mixtures of products, of:   a) moistening the freeze-dried food product or the freeze-dried mixture of products up to absolute moisture amounts of about 20 % depending on the kind of food product; b) compressing the moistened product by means of power-consuming machines at pressures between 2 and 100 kg/cm<2>; c) drying the compressed product till obtaining absolute moisture amounts less than or equal to 3 %. e
Patent HR-P20090554-T1 (HR)
Inventor: ORAWETZ UTA
IPC: B03B7/00
Filed: 2009-10-15
Abstract: Postupak za odlaganje otpada, naznačen time da obuhvaća sljedeće faze: (a) odvajanje metalnih dijelova, (b) odvajanje minerala + ostataka i plastičnih dijelova, te njihovo razdvajanje u obliku granulata, (c) sušenje preostalog otpada, (d) uklanjanje pepela iz osušenog preostalog otpada, (e) miješanje otpada bez pepela sa zrnatim plastičnim materijalom i kanalizacijskim muljem u podesivom omjeru, (f) oblikovanje izmiješanog proizvoda u pelete, (g) spaljivanje peleta radi proizvodnje energije. Patent sadrži još 17 patentnih zahtjeva.
Patent HR-P20110295-T1 (HR)
Inventor: RAGHAVAN SUBHAREKHA
IPC: A61K31/196
Filed: 2011-04-21
Abstract: Spoj predstavljen formulom I: ili njegova farmaceutski prihvatljiva sol ili solvat, naznačen time što: X predstavlja CH2, O, S, S(O), SO2 ili NH, tako da kada X predstavlja NH, atom dušika može po izboru biti supstituiran s R6, C(O)R6, ili SO2R6, gdje: R6 predstavlja C1-3alkil po izboru supstituiran s 1-3 skupine, od kojih su 0-3 halogen, a 0-1 se izabire iz grupe koja obuhvaća: OC1-3alkil, OH, NH2, NHC1-3alkil, N(C1-3alkil)2, CN, heterociklil (Hetcy), Aril i heteroaril (HAR), navedeni Aril i HAR su dalje po izboru supstituirani s 1-3 skupine, od kojih su 0-3 halogen, a 0-1 se izabire iz grupe koja obuhvaća skupine: OH, NH2, C1-3alkil, C1-3alkoksi, haloC1-3alkil i haloC1-3alkoksi; a i b su cijeli brojevi 1, 2 ili 3, tako da zbroj a i b bude 2, 3 ili 4; prsten A predstavlja aril sa 6-10 članova, heteroaril s 5-13 članova ili djelomično aromatsku heterocikličku skupinu, pri čemu navedeni heteroaril i djelomično aromatska heterociklička skupina sadržavaju barem jedan heteroatom izabran između O, S, S(O), S(O)2 i N, i po izboru sadržavaju 1 drugi heteroatom izabran između O i S, i po izboru sadržavaju 1-3 dodatna N atoma, tako da bude prisutno do 5 heteroatoma; svaki R2 i R3 je nezavisno H, C1-3alkil, haloC1-3alkil, OC1-3alkil, haloC1-3alkoksi, OH ili F; n predstavlja cijeli broj od 1 do 5; svaki R4 je H ili je nezavisno izabran između halogena i R6;R5 predstavlja -CO2H, ili -C(O)NHSO2Re gdje Re predstavlja C1-4alkil ili fenil, navedeni C1-4alkil i fenil su svaki po izboru supstituiran s 1-3 skupine, od kojih su 1-3 izabrane između halogena i C1-3alkil, a 1-2 su izabrane iz grupe koja obuhvaća: OC1-3alkil, haloC1-3alkil, haloC1-3alkoksi, OH, NH2 i NHC1-3alkil; i svaki R1 je H ili je nezavisno izabran iz grupe koja obuhvaćaa) halogen, OH, CO2H, CN, NH2,S(O)0-2Re, C(O)Re, OC(O)Re i CO2Re, pri čemu je Re kako je prethodno defniran; b) C1-6alkil i OC1-6alkil, pri čemu su navedeni C1-6alkil i alkilni dio u OC1-6alkil po izboru supstituirani s 1-3 skupine od kojih su 1-3 halogen, a 1-2 se izabiru između: OH, CO2H, CO2C1-4alkil, CO2C1-4halogenalkil, OCO2C1-4alkil, NH2, NHC1-4alkil, N(C1-4alkil)2, Hetcy i CN; c) NHC1-4alkil i N(C1-4alkil)2, čiji su alkilni dijelovi po izboru supstituirani kako je navedeno gore pod (b); d) C(O)NH2, C(O)NHC1-4alkil, C(O)N(C1-4alkil)2, C(O)Hetcy, C(O)NHOC1-4alkil i C(O)N(C1-4alkil)(OC1-4alkil), čiji su alkilni dijelovi po izboru supstituirani kako je navedeno gore pod (b); e) NR'C(O)R", NR'SO2R", NR'CO2R" i NR'C(O)NR"R"' gdje: R' predstavlja H, C1-3alkil ili halogenC1-3alkil, R" predstavlja (a) C1-8alkil po izboru supstituiran s 1-4 skupine od kojih su 0-4 halogen, a 0-1 se izabire iz grupe koja obuhvaća: OC1-6alkil, OH, CO2H, CO2C1-4alkil, CO2C1-4halogenalkil, NH2, NHC1-4alkil, N(C1-4alkil)2, CN, Hetcy, Aril i HAR, pri čemu su Hetcy, Aril i HAR dalje po izboru supstituirani s 1-3 halogena, C1-4alkil, C1-4alkoksi, halogenC1-4alkil ili halogenC1-4alkoksi skupinama; ili (b) Hetcy, Aril ili HAR, od kojih je svaki po izboru supstit
Patent SI-1411918-T1 (SI)
Title: Methods to mobilize progenitor/stem cells
Inventor: BRIDGER GARY J
IPC: A61K/
Filed: 2002-07-30
Abstract: Methods to elevate progenitor and stem cell counts in animal subjects using compounds which bind to the chemokine receptor CXCR4 are disclosed. Preferred embodiments of such compounds are of the formula Z-linker-Z' (1) or pharmaceutically acceptable salt thereof wherein Z is a cyclic polyamine containing 9-32 ring members of which 3-8 are nitrogen atoms, said nitrogen atoms separated from each other by at least 2 carbon atoms, and wherein said heterocycle may optionally contain additional heteroatoms besides nitrogen and/or may be fused to an additional ring system; or Z is of formula (a), wherein A comprises a monocyclic or bicyclic fused ring system containing at least one N and B is H or an organic moiety of 1-20 atoms, Z' may be embodied in a form as defined by Z above, or alternatively may be of the formula -N(R)-(CR<sub>2</sub>)<sub>n</sub>-X wherein each R is independently H or straight, branched or cyclic alkyl (1-6C), n is 1 or 2, and X is an aromatic ring, including heteroaromatic rings, or is a mercaptan; "linker" represents a bond, alkylene (1-6C) or may comprise aryl, fused aryl, oxygen atoms contained in an alkylene chain, or may contain keto groups or nitrogen or sulphur atoms.
Patent SI-2020243-T1 (SI)
Title: Topically applicable pharmaceutical preparation
Inventor: LINDER RUDOLF
IPC: A61K31/00
Filed: 2003-05-27
Abstract: A topical pharmaceutical preparation for administering a slightly soluble PDE 4 inhibitor is described. A surprisingly good systemic bioavailability is observed with this dosage form.
Patent SI-1721162-T1 (SI)
Title: Method of assessing rheumatoid arthritis by measuring anti-ccp and serum amyloid a
Inventor: WILD NORBERT
IPC: C07K14/00
Filed: 2005-02-23
Abstract: The present invention relates to a method aiding in the assessment of rheumatoid arthritis. The method especially is used in assessing the absence or presence of rheumatoid arthritis in vitro. It can be best practiced by analyzing biochemical markers, comprising measuring in a sample the concentration of anti-CCP and serum amyloid A and correlating the concentrations determined to the absence or presence of rheumatoid arthritis. To further improve the assessment of RA in a method of this invention the level of one or more additional marker may be determined together with anti-CCP and serum amyloid A and be correlated to the absence or presence of RA. The invention also relates to the use of a marker panel comprising anti-CCP and serum amyloid A in the diagnosis of rheumatoid arthritis and it teaches a kit for performing the method of the invention.
Patent SI-1956896-T1 (SI)
Title: Cryopreservation of hepatocytes
Inventor: ARSENIEV LUBOMIR
IPC: C12N5/071
Filed: 2006-11-03
Abstract: The invention relates to processes for the preparation of liver cells for cryopreservation, processes for cryopreservation of isolated liver cells and processes for the preparation of a culture of cryopreserved isolated liver cells.
Patent SI-2289838-T1 (SI)
Title: Filling device
Inventor: NEUMAYER WALTER
IPC: B67C3/00
Filed: 2009-11-26
Abstract: The device has a filling valve (4), a holder (7) in suspended arrangement, and a weighing device (9) assigned to the holder in close vicinity. The weighing device is arranged vertically above a container positioned in the holder. The holder is connected to the weighing device through a vertically extending arm (10a). The weighing device is arranged on two opposite sides and in symmetry with a filling axis (6'). The container is filled through the weighing device, where an outlet of the filling valve extends through the weighing device.
Patent SI-2972528-T1 (SI)
Title: Spun non-circular and non-elliptical fibers and apparatuses utilizing the same
Inventor: YE CHANGGENG
IPC: H01S3/00
Filed: 2014-03-17
Abstract: Optical fibers are provided for modal discrimination which include a central core and a cladding disposed about the central core. The central core has a non-circular and non- elliptical cross-section, and it is rotated about a central axis of the optical fiber along the length of the optical fiber at a selected pitch resulting in the capability of a fundamental mode beam output for large core sizes. An optical system includes a seed optical source configured to provide a seed beam and an optical amplifier configured to receive and amplify the seed beam. The optical amplifier also includes an active optical fiber having a large mode area non-circular and non-elliptical core rotated about a central axis of said active optical fiber to provide modal discrimination and fundamental mode output.
Patent TR-200002591-T1 (TR)
Inventor: ZHOU GUO-FU
IPC: G11B7/24097
Filed: 2000-01-06
Abstract: The application relates to methods and devices for determining the optimal erase (17) and write powers for erasing and writing information on an optical record carrier (85). These optimal powers are determined from two powers, Pmin (15) and Pmax (16), found at specific points, (22) and (24), in a curve (10) where the normalized reflected power (12) is plotted versus the test power (11).
Patent DE-3780505-T2 (DE)
Inventor: OMINATO KIYOSHI
IPC: B42F13/14
Filed: 1987-04-28
Granted: 1992-12-17
Abstract: A binding device is disclosed, which comprises a fixture (40) having at least two binding rods (46), a cover plate (42) having means (50, 50a) for engaging with ends of the binding rods (46) and an elastically displaceable connection (44) providing a pluraity of divided elastic piece members (60) for interconnecting the fixture (40) with the cover plate (42) at their longitudinal ends, wherein the fixture (40), the cover plate (42) and the elastic connection (44) are integrally and displaceably formed.